Qingyangshengenin B (Otophylloside B) is a C-21 steroidal glycoside with neuroprotective properties, notably reducing Abeta peptide expression and deposition. Research demonstrates its in vivo efficacy in extending lifespan and enhancing stress resistance in C. elegans AD models, alongside exhibiting antiepileptic activity in zebrafish seizure assays.